105 related articles for article (PubMed ID: 8940197)
1. Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits.
Li J; Cook R; Chaiken I
J Biol Chem; 1996 Dec; 271(49):31729-34. PubMed ID: 8940197
[TBL] [Abstract][Full Text] [Related]
2. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
Plugariu CG; Wu SJ; Zhang W; Chaiken I
Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
[TBL] [Abstract][Full Text] [Related]
3. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites.
Li J; Cook R; Dede K; Chaiken I
J Biol Chem; 1996 Jan; 271(4):1817-20. PubMed ID: 8567620
[TBL] [Abstract][Full Text] [Related]
4. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.
Tavernier J; Tuypens T; Verhee A; Plaetinck G; Devos R; Van der Heyden J; Guisez Y; Oefner C
Proc Natl Acad Sci U S A; 1995 May; 92(11):5194-8. PubMed ID: 7761472
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation.
Ishino T; Pillalamarri U; Panarello D; Bhattacharya M; Urbina C; Horvat S; Sarkhel S; Jameson B; Chaiken I
Biochemistry; 2006 Jan; 45(4):1106-15. PubMed ID: 16430207
[TBL] [Abstract][Full Text] [Related]
6. Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition.
Ishino T; Pasut G; Scibek J; Chaiken I
J Biol Chem; 2004 Mar; 279(10):9547-56. PubMed ID: 14662768
[TBL] [Abstract][Full Text] [Related]
7. Receptor epitope usage by an interleukin-5 mimetic peptide.
Ishino T; Urbina C; Bhattacharya M; Panarello D; Chaiken I
J Biol Chem; 2005 Jun; 280(24):22951-61. PubMed ID: 15826943
[TBL] [Abstract][Full Text] [Related]
8. Biosensor analysis of dynamics of interleukin 5 receptor subunit beta(c) interaction with IL5:IL5R(alpha) complexes.
Scibek JJ; Evergren E; Zahn S; Canziani GA; Van Ryk D; Chaiken IM
Anal Biochem; 2002 Aug; 307(2):258-65. PubMed ID: 12202242
[TBL] [Abstract][Full Text] [Related]
9. Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5.
Li C; Plugariu CG; Bajgier J; White JR; Liefer KM; Wu SJ; Chaiken I
J Mol Recognit; 2002; 15(1):33-43. PubMed ID: 11870920
[TBL] [Abstract][Full Text] [Related]
10. Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly.
Ishino T; Harrington AE; Zaks-Zilberman M; Scibek JJ; Chaiken I
Cytokine; 2008 May; 42(2):179-190. PubMed ID: 18294864
[TBL] [Abstract][Full Text] [Related]
11. Randomization of the receptor alpha chain recruitment epitope reveals a functional interleukin-5 with charge depletion in the CD loop.
Wu SJ; Li J; Tsui P; Cook R; Zhang W; Hu Y; Canziani G; Chaiken I
J Biol Chem; 1999 Jul; 274(29):20479-88. PubMed ID: 10400676
[TBL] [Abstract][Full Text] [Related]
12. Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5.
Devos R; Guisez Y; Plaetinck G; Cornelis S; Tavernier J; van der Heyden J; Foley LH; Scheffler JE
Eur J Biochem; 1994 Oct; 225(2):635-40. PubMed ID: 7957178
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors.
Stomski FC; Woodcock JM; Zacharakis B; Bagley CJ; Sun Q; Lopez AF
J Biol Chem; 1998 Jan; 273(2):1192-9. PubMed ID: 9422786
[TBL] [Abstract][Full Text] [Related]
14. Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function.
Li J; Cook R; Doyle ML; Hensley P; McNulty DE; Chaiken I
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6694-9. PubMed ID: 9192627
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor.
Morton TA; Bennett DB; Appelbaum ER; Cusimano DM; Johanson KO; Matico RE; Young PR; Doyle M; Chaiken IM
J Mol Recognit; 1994 Mar; 7(1):47-55. PubMed ID: 7986567
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.
Banks M; Graber P; Proudfoot AE; Arod CY; Allet B; Bernard AR; Sebille E; McKinnon M; Wells TN; Solari R
Anal Biochem; 1995 Sep; 230(2):321-8. PubMed ID: 7503425
[TBL] [Abstract][Full Text] [Related]
17. Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.
Rajotte D; Cadieux C; Haman A; Wilkes BC; Clark SC; Hercus T; Woodcock JA; Lopez A; Hoang T
J Exp Med; 1997 Jun; 185(11):1939-50. PubMed ID: 9166423
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition.
Morton T; Li J; Cook R; Chaiken I
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10879-83. PubMed ID: 7479902
[TBL] [Abstract][Full Text] [Related]
19. Creation of a biologically active interleukin-5 monomer.
Dickason RR; Huston DP
Nature; 1996 Feb; 379(6566):652-5. PubMed ID: 8628400
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains.
Murphy JM; Ford SC; Olsen JE; Gustin SE; Jeffrey PD; Ollis DL; Young IG
J Biol Chem; 2004 Jun; 279(25):26500-8. PubMed ID: 15060062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
